ATHENA Sweeps 8 Criteria in Blind Tests Across 28 Rare Disease Groups
marinkazitnik · x · 2026-07-07
A research team invited domain experts from 28 rare disease organizations within the Biohub Rare As One network to conduct blind evaluations comparing ATHENA against reference models. The assessment covered various therapeutic cases, including neurodevelopmental disorders, epilepsy, metabolic diseases, and rare cancers. ATHENA outperformed baseline models across all 8 evaluation criteria, showing the most significant improvements in cognitive traceability and the helpfulness of its reasoning. Experts particularly praised its ability to provide evidence chain visualizations.
More from Research
- 3D ResNet Paper Crosses 3,000 Citations Eight Years After CVPR 2018 — HirokatuKataoka · 2026-09-11
- Jeff Heaton's Intro to the Math of Neural Networks eBook Is Free to Download — blaizedsouza · 2026-09-11
- Mathematician Daniel Litt Launches Problem Repo to Track Human vs AI Progress: 15 Problems, 1 Solved — littmath · 2026-09-11
- Open ECDSA.fail challenge uses AI agents to shrink Shor's-algorithm quantum circuits for Bitcoin keys — StefanoGogioso · 2026-09-11
- Alex Townsend posts 200 open problems in numerical linear algebra for humans and AI agents — IgorCarron · 2026-09-11
- Navier-Stokes, Riemann, P vs NP: what this week's math buzzwords mean for you — koltregaskes · 2026-09-11